Why Our Wegovy Price List Shows Every Cost Upfront
Complete Wegovy Price List Transparency - What Others Hide
Unlike other UK pharmacies that advertise low Wegovy prices then add consultation fees, prescription charges, and delivery costs, our Wegovy price list shows your final cost upfront. Many competitors charge £50-80 consultation fees on top of medication costs, effectively doubling your spend. Our prices include everything: the 3-minute clinical assessment, prescriber review by our GPhC-registered clinical team (#9012878), prescription generation, and your Wegovy FlexTouch pen.
This transparent approach means you can budget accurately for your weight management journey without worrying about surprise charges. When you see £79.99 for our 0.25mg starter dose, that's your complete cost - not the beginning of a pricing maze designed to extract extra fees once you've committed to purchase.
Our Complete Wegovy Price List - All Doses and Bundles
Our single pen Wegovy price list covers all licensed doses: 0.25mg starter pens at £79.99, 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the 2.4mg maintenance dose at £209.99. These prices apply after using discount codes FIRST40 for new customers or DOSE25 for returning patients - codes that bring you to these final prices, not add extra discounts on top.
Our bundle options provide supply continuity without multiple orders. The Intro Duo (0.25mg & 0.5mg) costs £169.99, while our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. Every price on our Wegovy price list represents your complete cost with no hidden extras, allowing you to choose the option that suits your treatment timeline and budget.
Clinical Evidence Supporting Our Wegovy Price List Investment
In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at two years, while the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events.
These results may help justify the investment shown in any Wegovy price list, as this prescription-only medicine has demonstrated consistent efficacy when used alongside a reduced-calorie diet and increased physical activity. The clinical evidence supports Wegovy as a long-term weight management tool rather than a short-term solution.
How Wegovy Justifies Its Position in the UK Price List Market
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. This mechanism may help reduce appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals and potentially reducing food cravings. Unlike appetite suppressants that simply block hunger signals, Wegovy works with your body's existing satiety pathways to support natural portion control. The once-weekly FlexTouch pen delivery system maintains steady medication levels, supporting consistent appetite regulation throughout your weight management journey.
Our Streamlined Ordering Process Behind Every Wegovy Price List
Accessing our transparent Wegovy price list starts with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescriber team (GPhC #9012878) reviews your assessment within 3 working days (24 hours with express service), ensuring Wegovy is clinically appropriate for your situation. Once approved, your FlexTouch pen ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirement throughout transport. This integrated process eliminates the separate consultation bookings and prescription collection steps that add costs and complexity at other pharmacies.
Practical Storage and Usage Supporting Our Wegovy Price List Value
Your Wegovy FlexTouch pen requires refrigerated storage at 2-8°C before first use, but can remain at room temperature below 30°C for up to 6 weeks once removed from the fridge - longer than Mounjaro's 21-day room temperature limit. The mandatory dose escalation schedule (0.25mg for weeks 1-4, 0.5mg for weeks 5-8, continuing to 2.4mg maintenance) cannot be skipped, making accurate price planning essential. Each pen contains four weekly doses, with the injection administered once weekly on the same day. The FlexTouch system requires no mixing or preparation, simply attach a new needle and inject subcutaneously into your thigh, abdomen, or upper arm.
Why Our Wegovy Price List Stands Apart from Competitor Fee Structures
Most UK online pharmacies split Wegovy costs into medication price plus consultation fees, creating a two-tier pricing structure that obscures true costs until checkout. Our Wegovy price list philosophy eliminates this practice by incorporating all necessary clinical services into a single transparent price. This approach prevents the common scenario where patients budget for a £60 medication cost, only to discover an additional £70 consultation fee at payment.
We've also eliminated subscription models that lock patients into automatic renewals or membership fees. Every purchase on our Wegovy price list represents a standalone transaction with no ongoing commitments, giving you complete control over your treatment timeline and budget without pressure to maintain costly monthly subscriptions.
Access Our Complete Wegovy Price List - No Surprises Assured
Ready to start your weight management journey with complete price transparency? Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to access our full price list and begin your clinical assessment. New customers can use code FIRST40 at checkout, while returning patients should apply code DOSE25 to reach our published prices. Our clinical team (GPhC #9012878) stands ready to review your assessment and ensure Wegovy is appropriate for your weight management goals alongside a reduced-calorie diet and increased physical activity. Experience the difference of honest pricing in UK healthcare.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
